@article{589ff3f8ed9e4156aa84508f3881c38d,
title = "Levetiracetam and non-Vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and epilepsy: A reasonable combination",
author = "{Von Oertzen}, {Tim J.} and Eugen Trinka and Bornstein, {Natan M.}",
note = "Funding Information: Conflict of interest: Dr von Oertzen reports grants, personal fees and non-financial support from UCB Pharma GmbH Vienna, grants; personal fees and non-financial support from Novartis Pharma; personal fees from Roche Pharma, Biogen Idec Austria, Liva Nova, Sanofi-Genyzme GmbH; grants from Grossegger & Drbal GmbH, Merck; personal fees from Indivior Austria GmbH, Medizin Medien Austria; personal fees and non-financial support from gtec GmbH Austria; personal fees from Boehringer-Ingelheim, outside the submitted work; and he is web editor in chief of the European Academy of Neurology (EAN), and vice-president of the {\"O}sterreichische",
year = "2019",
month = dec,
day = "7",
doi = "10.1093/eurheartj/ehz657",
language = "אנגלית",
volume = "40",
pages = "3800--3801",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "46",
}